Samantha J. Anderson

Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity

M. Burkard, J. Kratz, I. Ong, 2021, bioRxiv.

Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series.

K. Brady, B. Tolliver, A. McRae, 2008, Journal of clinical psychopharmacology.

An Open-Label Trial of Aripiprazole Treatment in Dual Diagnosis Individuals: Safety and Efficacy

K. Brady, R. Carter, A. Wahlquist, 2009 .